SL-251131
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
SL-251131 is a reversible non-specific MAO inhibitor. SL-251131 temporarily blocks both MAO-A and MAO-B enzymes, which are responsible for breaking down neurotransmitters like dopamine. SL-251131 can be used for the study of Parkinson's disease[1].
176773-86-7
12352005
Monoamine Oxidase
Neuronal Signaling
Neurological Disease
O=C1N2C3=CC=C(OCCCC(F)(F)F)C=C3CC[C@@]2([H])[C@H](O1)COC
C17H20F3NO4
359.34
[1]Korczyn AD, Nussbaum M. Emerging therapies in the pharmacological treatment of Parkinson’s disease. Drugs. 2002 Apr;62 (5) :775-86.
Room temperature
http://file.medchemexpress.com/batch_PDF/HY-106972/
Reference compound1
No Development Reported
Beschrijving
SL-251131 is a reversible non-specific MAO inhibitor. SL-251131 temporarily blocks both MAO-A and MAO-B enzymes, which are responsible for breaking down neurotr
Specificaties
Recent bekeken producten
0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs
Erdafitinib
B2458-25
25 mg
TRPM4-IN-2
BA7024-1
1 mg
TRPM4-IN-1
HY-122605-01
5 mg
Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg
Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg
GelRed® Agarose LE
#41029-5G
1x 5 g
50 ml Disposable Serological Pipette
CPP00050
100/CS
